Add like
Add dislike
Add to saved papers

Stent thrombosis in patients with drug‑‑eluting stents and bioresorbable vascular scaffolds: the feared complication.

The percutaneous coronary intervention (PCI) has undergone rapid evolution over the last 40 years and has become one of the most widely performed medical procedures. The introduction of intracoronary stents has improved the safety and efficacy of PCI. However, with the advent of stenting, a new potentially fatal enemy has emerged: stent thrombosis. Ever since, adjunct pharmacological therapy, stent technique, and technology have been adjusted to reduce the risk of stent thrombosis. The aim of the present article is to provide an overview of the past, present, and future aspects of PCI in relation to stent thrombosis.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app